安徽医科大学学报2024,Vol.59Issue(6) :988-993.DOI:10.19405/j.cnki.issn1000-1492.2024.06.012

生长激素预处理在胚胎植入前染色体非整倍体检测中的应用研究

Application of growth hormone pretreatment in preimplantation genetic testing for aneuploidy

周海燕 吴彩云 黄德焕 郝燕 陈大蔚 王孟寒 赵刚 周平
安徽医科大学学报2024,Vol.59Issue(6) :988-993.DOI:10.19405/j.cnki.issn1000-1492.2024.06.012

生长激素预处理在胚胎植入前染色体非整倍体检测中的应用研究

Application of growth hormone pretreatment in preimplantation genetic testing for aneuploidy

周海燕 1吴彩云 2黄德焕 2郝燕 2陈大蔚 2王孟寒 3赵刚 3周平4
扫码查看

作者信息

  • 1. 安徽医科大学第一附属医院妇产科,合肥 230032;安徽医科大学附属巢湖医院妇产科,巢湖 238000;国家卫生健康委配子及生殖道异常研究重点实验室,合肥 230032
  • 2. 安徽医科大学第一附属医院妇产科,合肥 230032;生殖健康与遗传安徽省重点实验室,合肥 230032;安徽省生命资源保存与人工器官工程技术研究中心,合肥 230032
  • 3. 中国科学技术大学电子工程与信息科学系,合肥 230027
  • 4. 安徽医科大学第一附属医院妇产科,合肥 230032;国家卫生健康委配子及生殖道异常研究重点实验室,合肥 230032
  • 折叠

摘要

目的 研究生长激素(GH)预处理对整倍体的改善及妊娠结局的影响.方法 前瞻性分析行胚胎植入前染色体非整倍体检测(PGT-A)助孕的134例患者,其中30例行自身对照,104例行组间对照.根据是否添加GH分为GH预处理组和GH非预处理组,GH预处理为促性腺激素(Gn)启动前行4~6周的GH 2 U/d皮下注射,Gn启动日剂量加倍直至扳机日,GH非预处理为未用过GH处理.前次PGT-A周期失败后一年内再次行PGT-A时予GH预处理构成自身对照组.组间对照和自身对照分别比较各组间的基本情况、囊胚情况及助孕结局.结果 无论组间对照还是自身对照,GH预处理后的HCG日子宫内膜厚度、卵巢敏感指数(OSI)、获卵数、MII卵数、2PN数、2PN受精率、可利用卵母细胞率、活检囊胚数、整倍体囊胚数、整倍体囊胚率、至少一个整倍体率均明显增加,差异均有统计学意义(P<0.05),GH预处理后的Gn总量、Gn天数、嵌合体囊胚数、嵌合体囊胚率无明显变化,差异均无统计学意义,GH预处理后的种植率、临床妊娠率均有提高,但差异均无统计学意义.结论 GH预处理可以明显增加行PGT-A患者的整倍体数和整倍体率,并有改善妊娠结局的趋势.

Abstract

Objective To investigate the effect of growth hormone(GH)pretreatment on the improvement of eu-ploid and pregnancy outcome.Methods A prospective analysis was conducted on 134 patients undergoing preim-plantation genetic testing for aneuploidy(PGT-A),among whom 30 patients were self-controlled and 104 patients were inter-group controlled.According to whether GH was added,the patients were divided into GH pretreatment group and GH non-pretreatment group.GH pretreatment included subcutaneous injection of GH 2U/day for 4-6 weeks before the start of gonadotropin(Gn),and the dose was doubled on the day of Gn until the trigger day.GH non-pretreatment meant no GH treatment,GH pretreatment was given when the previous PGT-A cycle failed within one year when the PGT-A was performed again,forming the self-control group.The basic situation,blastocyst situa-tion and pregnancy outcome were compared between the groups by inter-group and self-control.Results No matter in the group control or self-controlled group,the endometrial thickness on the day of HCG,ovarian sensitivity index(OSI),number of oocytes obtained,MII oocytes,2PN number,2PN fertilization rate,available oocyte rate,num-ber of biopsy blastocysts,number of euploid blastocysts,euploid blastocyst rate,and at least one euploid rate sig-nificantly increased after GH pretreatment,with statistically significant differences(P<0.05).The total amount of Gn,Gn days,number of mosaic blastocysts,and mosaic blastocyst rate were not significantly changed after GH pretreatment,with no statistically significant differences.The implantation rate and clinical pregnancy rate in-creased after GH pretreatment,but with no statistically significant differences.Conclusion GH pretreatment can significantly improve the number and rate of euploid embryos in patients undergoing PGT-A,and has a tendency to improve pregnancy outcome.

关键词

生长激素预处理/胚胎植入前染色体非整倍体检测/整倍体/妊娠结局

Key words

growth hormone pretreatment/preimplantation genetic testing for aneuploidy/euploid/pregnancy out-come

引用本文复制引用

基金项目

国家自然科学基金(82301896)

安徽科技重大专项(202003a07020012)

出版年

2024
安徽医科大学学报
安徽医科大学

安徽医科大学学报

CSTPCD北大核心
影响因子:1.095
ISSN:1000-1492
参考文献量16
段落导航相关论文